Form 4: Oscar Health Director Exercises Stock Options, Acquires Shares

Oscar Health director Jeffery H. Boyd exercised stock options to acquire 577,027 shares of Class A Common Stock at $4.29 per share.

Summary

• Jeffery H. Boyd, a director at Oscar Health, Inc., exercised stock options on November 12, 2024.
• This transaction involved the acquisition of 577,027 shares of Class A Common Stock at a price of $4.29 per share.
• Following the transaction, Mr. Boyd directly owns 691,539 shares of Class A Common Stock.
• The stock options were fully vested and exercisable on the transaction date.
• The options were set to expire on February 21, 2025.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction. It is neither particularly positive nor negative, but the exercise of options by a director can be seen as a sign of confidence.

Positives

• The exercise of stock options by a director could be seen as a positive sign of confidence in the company's future prospects.
• The director now has a larger stake in the company.

Industry Context

This is a standard transaction for a company with stock options as part of its compensation structure. It is common for directors to exercise options as they vest.

Comparison to Industry Standards

• Stock option exercises are a common practice among publicly traded companies, particularly for directors and executives.
• The exercise price of $4.29 is specific to Oscar Health's stock option plan and is not directly comparable to other companies without knowing their specific option terms.
• The number of shares acquired is significant but not unusual for a director's stock option exercise.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning his interests with those of other shareholders.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, Form 4, Oscar Health, OSCR, Class A Common Stock, director